LYRA THERAPEUTICS INC's ticker is LYRA and the CUSIP is 55234L105. A total of 32 filers reported holding LYRA THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is 0.12 and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $3,613,505 | -4.9% | 924,170 | 0.0% | 0.38% | -37.4% |
| Q2 2023 | $3,798,339 | +104.5% | 924,170 | 0.0% | 0.61% | +67.2% |
| Q1 2023 | $1,857,582 | -36.0% | 924,170 | 0.0% | 0.36% | -25.8% |
| Q4 2022 | $2,901,894 | -37.3% | 924,170 | 0.0% | 0.49% | -31.5% |
| Q3 2022 | $4,630,000 | -11.3% | 924,170 | 0.0% | 0.71% | -30.5% |
| Q2 2022 | $5,222,000 | – | 924,170 | – | 1.03% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Samsara BioCapital, LLC | 1,777,251 | $10,041,000 | 2.68% |
| Perceptive Advisors | 9,146,730 | $51,679,000 | 1.62% |
| VR Adviser, LLC | 924,170 | $5,222,000 | 1.03% |
| PURA VIDA INVESTMENTS, LLC | 2,576,196 | $14,556,000 | 0.84% |
| Nantahala Capital Management | 2,369,668 | $13,389,000 | 0.67% |
| Soleus Capital Management, L.P. | 592,417 | $3,347,000 | 0.52% |
| Ikarian Capital, LLC | 347,338 | $1,963,000 | 0.36% |
| Clearline Capital LP | 119,128 | $673,000 | 0.09% |
| CVI Holdings, LLC | 60,822 | $344,000 | 0.02% |
| HighMark Wealth Management LLC | 4,000 | $23,000 | 0.02% |